Sydney medtech startup cracks medical imaging milestone
Backed by Blackbird, Sydney’s Vexev has clinically proven a world-first autonomous ultrasound robot, performing specialist scans at the press of a button.
In a world first for autonomous medical imaging, a 25-person team from Sydney’s Surry Hills has clinically validated an autonomous ultrasound robot capable of performing specialist-grade vascular scans at the press of a button.
Blackbird-backed Vexev’s CANSCAN trial, conducted across three dialysis clinics in San Antonio, Texas, achieved a 94% scan completion rate and a 100% data adequacy rate across 115 patients with severe kidney disease.
The breakthrough is that all scans were performed by existing dialysis staff rather than vascular specialists, with the device meeting the gold standard for clinical outcomes.
“We’re the first and only ones to have actually proven this,” Vexev co-founder John Carroll told Capital Brief.
